This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Leptochloa fusca is a new dominant grass weed in paddy ecosystem of local region in China. The extensive herbicide application has selected the cyhalofop-butyl-resistant L. fusca populations. Here, we aimed to (i) characterize the target-site resistance mechanisms to ACCase inhibitors, and (ii) establish an efficient and rapid method for detecting mutations. RESULTS: The L. fusca population (SFC-R) was resistant to cyhalofop-butyl (RF = 5.4), metamifop (RF = 5.5), and fenoxaprop-P-ethyl (RF = 6.8). Gene sequencing revealed that the Ile-1781-Val mutation was the molecular basis of resistance. A recombinase-aided amplification (RAA) combined with CRISPR/Cas12a method was successfully developed, which could rapidly and visually detect the single nucleotide variation underling the Ile-1781-Val substitution in L. fusca. CONCLUSION: This study confirmed that target-site mutation (Ile-1781-Val) endowed resistance to ACCase inhibitors in L. fusca, and represented the first report of applying the RAA-CRISPR/Cas12a assay for mutation detection in resistant weeds. Considering its simplicity and specificity, this technique may be used in monitoring and early warning of resistant weeds.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: